C. Gelber et al., ISOLATION OF NONOBESE DIABETIC MOUSE T-CELLS THAT RECOGNIZE NOVEL AUTOANTIGENS INVOLVED IN THE EARLY EVENTS OF DIABETES, Diabetes, 43(1), 1994, pp. 33-39
Citations number
38
Categorie Soggetti
Endocrynology & Metabolism","Medicine, General & Internal
Insulin-dependent diabetes mellitus (IDDM) is thought to result from c
hronic, cell-mediated, autoimmune islet damage. Our aim was to identif
y the earliest T-cell autoantigen in IDDM, reasoning that this antigen
could be causally involved in the initiation of the disease. Identifi
cation of the earliest beta-cell-specific autoantigen is extremely imp
ortant in allowing advances in prevention and treatment of initial eve
nts in the development of inflammatory insulitis that precedes beta-ce
ll destruction and overt diabetes. Therefore, we analyzed the prolifer
ative responses of peripheral T-cells from young, female nonobese diab
etic (NOD) mice to extracts of pancreatic beta-cell lines. We were abl
e to demonstrate that T-cells responsive to beta-cell antigens exist i
n the peripheral lymphoid tissue of these mice in the absence of delib
erate priming before the manifestation of histologically detectable in
sulitis. T-cell lines and clones isolated from the peripheral lymphati
c tissues of young, unimmunized, female NOD mice were also shown to re
act with extracts of beta-cells. Fractionation of the beta-cell extrac
ts showed that these T-cell clones recognized multiple beta-cell-speci
fic autoantigens but none of the previously reported putative autoanti
gens (glutamic acid decarboxylase [GAD]65, GAD67, Hsp65, insulin, ICA
69, carboxypeptidase-H, and peripherin). Thus, we can conclude that th
ese responses are specific for novel beta-cell autoantigens. Finally,
NOD T-cell proliferative responses were also seen to an extract of hum
an islets suggesting potential shared antigenic determinants between h
uman and mouse beta-cells. Our observation that human and murine beta-
cell-specific antigens are conserved offers the possibility that ident
ification of these murine autoantigens may lead to the discovery of th
e human homologue. This will pave the way toward effective diagnosis a
nd/or immunotherapy to prevent diabetes.